
Cardinal Health stays a Buy with strong FY2026 results and promising FY2027 earnings growth guidance.
Cardinal Health reported robust fiscal year 2026 results, including 14% revenue growth, a 20% increase in gross margin, and doubled free cash flow. Despite challenges like thin margins and higher current liabilities, the company remains strong with F...

